A 3D SPHEROID MODEL AS A PLATFORM TO STUDY NON-VIRAL GENE DELIVERY SYSTEM by Chen, Yuzhe
 A 3D SPHEROID MODEL AS A PLATFORM TO STUDY NON-VIRAL GENE 
DELIVERY SYSTEM 
 
 
 
 
 
 
 
 
by 
Yuzhe Chen 
BS, Zhejiang University, College of Pharmaceutical Science, 2009  
 
 
 
 
 
 
 
 
 
Submitted to the Graduate Faculty of 
School of Pharmacy in partial fulfillment  
of the requirements for the degree of 
Master of Science 
 
 
 
 
 
 
 
 
 
University of Pittsburgh 
2015 
 
 ii 
UNIVERSITY OF PITTSBURGH 
School of Pharmacy 
 
 
 
 
 
 
 
 
This thesis was presented 
 
by 
 
 
Yuzhe Chen 
 
 
 
It was defended on 
July 23, 2015 
and approved by 
Dr. Shilpa Sant, Assistant Professor, School of Pharmacy 
Dr. Jiang Li, Associated Professor, School of Pharmacy 
Dr. Vinayak Sant, Assistant Professor, School of Pharmacy 
 Thesis Director Advisor: Dr. Shilpa Sant, Assistant Professor, School of Pharmacy 
 
 iii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright © by Yuzhe Chen 
2015 
 iv 
Non-viral gene delivery has emerged as a promising strategy in the past two decades for gene 
therapy. However, it is difficult to translate non-viral gene delivery into clinical trials. This is 
because of the low transfection efficiency of non-viral vectors and little knowledge about 
transfection mechanism in 3D tissues. The complex microenvironment of 3D tissues results in 
the poor relevance of non-viral transfection in conventional 2D monolayer cells and 3D tissues. 
Here, we develop a 3D multicellular spheroid model to increase the understanding of the gene 
delivery process by non-viral vectors in 3D tissues. We synthesized Spermine-conjugated-
Dextran (SD), non-viral vector, for gene delivery to 3D tissues. Then, we utilized micro-
fabrication technique to prepare 3D spheroids with uniform size in a high throughput manner. 
We compared the transfection of SD/DNA nanocomplexes in 2D cells and 3D spheroids. Our 
results revealed that the transfection efficiency and cytotoxicity of non-viral vectors were lower 
in 3D spheroids than those in 2D monolayer cells. We used confocal microscopy to visualize the 
cellular uptake of SD/DNA complex in monolayer cells and spheroids. The results demonstrated 
that SD vector was limited to the external layers of cells in 3D spheroids and couldn’t penetrate 
into the core of spheroids. Taken together, our study indicates that the non-viral transfection 
behavior in 3D spheroid model is different from that in 2D cells, and this model may be more 
relevant to in vivo setting than that of conventional 2D monolayer cell models. This system also 
provides a useful high throughput in vitro screening platform for the novel non-viral gene 
delivery system testing in the future. 
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1.0  INTRODUCTION 
The success of gene therapy largely depends on the delivery system, which should have desired 
transfection efficiency with low cytotoxicity. Despite the high transfection efficiency of viral 
vectors, the safety concerns such as carcinogenesis, immunogenicity and risks of mutation have 
limited their use clinically [2, 3]. As a result, non-viral vectors have gained tremendous attention 
as an alternative delivery system due to their non-immunogenicity, ease of modification, low 
toxicity and low production cost. Unfortunately, even if non-viral systems show good 
transfection efficiency in cultured monolayer two dimensional (2D) cell lines in vitro, the 
efficacy of in vivo non-viral gene delivery is not sufficient to provide therapeutic benefits. Due to 
the complex microenvironment in vivo, very little is known about the mechanism of gene 
delivery in in vivo tissues with three dimensional (3D) architectures. The obstacle in solving this 
problem is the poor relevance of non-viral transfection in conventional 2D monolayer cells and 
3D tissues. Therefore, it is urgent to develop more relevant in vitro models for studying the gene 
delivery in 3D tissues in vitro as well as for screening the newly developed non-viral gene 
delivery systems prior to the pre-clinical in vivo study. 
3D multicellular spheroids of stem cells and cancer cells have been generated for tissue 
regeneration [12] and anti-cancer drug testing [13], respectively. 3D models have been employed 
as a platform for drug testing because they can recapitulate cell–cell and cell-ECM interaction 
and tissue mechanical properties [15, 21]. These 3D spheroid models have been used for 
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evaluations of drug sensitivity and resistance [34, 40]. Also, 3D models were applied to 
investigate effect of microenvironmental factors such as oxygen tension and nutrient 
consumption in 3D structure on the mechanism of drug or gene delivery [22]. There are several 
advantages of spheroids as a platform for drug/gene delivery testing. First, 3D spheroids can 
mimic 3D tissue architecture so that they can be used to better predict the performance of the 
delivery system in vivo than in 2D monolayer cells. This is because 3D spheroid model includes 
cell-cell and cell-ECM interaction as well as the diffusional limitation observed in vivo. 
Moreover, 3D spheroid models can mimic characteristic spatial distribution of cells in the solid 
tumor having central necrosis and hypoxia in their core, which is important for testing the anti-
cancer drugs or gene delivery in these areas [33]. Compared to the wide application of 3D 
spheroids for testing chemotherapeutic drugs and stem cell regeneration [6, 42], there are less 
studies on the gene delivery research in 3D spheroid model except few reporting the physical 
electroporation transfection [29, 43] and the oligonucleotide delivery [5]. 
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Figure 1. Schematic showing fabrication of non-viral nanocomplexes and their transfection efficiency 
tested in 2D vs 3D multicellular spheroids 
The aim of this study was to increase our understanding of the transfection process of 
non-viral gene delivery vectors in a 3D spheroid model (Figure 1). Thus, our strategy was to 
construct uniform size 3D spheroids using HeLa cells and our novel polydimethyl siloxane 
(PDMS) micro-array technique. We also synthesized spermine-conjugated-dextran (SD) as a 
non-viral vector for the gene delivery into 3D spheroids. Then, cytotoxicity and transfection 
behavior of SD were compared with most widely used non-viral vector, branched 
polyethyleneimine (PEI, 25 kDa) in both conventional 2D monolayer cells and 3D spheroids. 
Finally, we compared the cellular uptake of the fluorescently labeled SD in 2D cells and 3D 
spheroids to investigate the possible mechanism that resulted in the differential transfection 
efficiency. Our study helps understanding the transfection process of non-viral gene delivery 
system in 3D spheroids, which is critical for the improvement and advancement of this 
therapeutic strategy. Also, this 3D spheroid model may be more relevant to in vivo setting and 
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may provide a useful high throughput in vitro screening platform for the novel non-viral gene 
delivery system in the future. 
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2.0  MATERIALS AND METHODS 
2.1 Materials and Cells 
All the chemicals were purchased from Sigma-Aldrich (USA) unless mentioned otherwise. Cell 
culture media, DMEM (Dulbecco’s Modified Eagle Medium, 1X with 4.5g/L glucose, L-Glut 
and Sodium pyruvate), Dulbecco’s phosphate buffered saline (DPBS) and serum were purchased 
from Mediatech Inc. (Manassas, USA). HeLa cell line and pLG2-Luc reporter plasmid were 
kindly provided by Dr. Song Li (School of Pharmacy, University of Pittsburgh, PA). HeLa cells 
were cultured in DMEM containing 10% fetal bovine serum (FBS, Hyclone, USA) under sterile 
conditions and maintained in 5% CO2 at 37°C in a humidified incubator. RIPA (Radio-
Immunoprecipitation Assay) buffer used for cell lysis samples in western blot was prepared 
using Tris (50 mM), pH 7.4, NaCl (150 mM), 0.5% sodium deoxycholate, 1% NP-40, 0.05 mM 
PMSF and protease inhibitor cocktail. Propidium iodide (PI) was purchased from 
Immunochemistry Technologies, LLC (USA). Hoechst 33342 was obtained from Thermo Fisher 
(USA). An enhanced green fluorescent protein plasmid (pcDNA3-EGFP, #13031) was purchased 
from Addgene (USA). It was propagated in Escherichia coli (E. coli) and isolated using DNA 
purification kit, GeneJET Plasmid Maxiprep Kit (Thermo Fisher, USA) as per the 
manufacturer’s protocol. 
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2.2 Synthesis of Spermine-Conjugated Dextran (SD) 
SD was synthesized according to previous report with slight modification [7]. Briefly, dextran 
(50 mg, Mw 70,000) was dissolved in 5 mL dimethyl sulfoxide (DMSO) followed by addition of 
450 mg of carbonyldiimidazole (CDI) (molar ratio [CDI] / [OH] = 3) to activate the dextran. The 
activated dextran was then gradually added to 45 mL DMSO containing 1873.5 mg spermine 
with constant stirring and the reaction was continued for 24 h at room temperature. The crude 
product was dialyzed (MWCO 12-14 kDa) against ultrapure water for 48 h and lyophilized for 3 
days to get the purified SD. The synthesis of SD was confirmed by Fourier transform infrared 
(FTIR) spectroscopy and proton nuclear magnetic resonance (1H-NMR) spectroscopy. For FTIR, 
the spectra were recorded in absorption mode with a resolution of 4 cm-1 using FTIR 
spectrometer (Bruker Vertex 70, USA) with attenuated total reflection (ATR) attachment at a 
frequency range of 4000-600 cm-1. For 1H-NMR, the polymer samples were dissolved in 
CDCl3 and the spectra were recorded by a NMR (Bruker 400, USA) at 400 MHz. Rhodamine-
labeled SD (RSD) was also synthesized by conjugating spermine with Rhodamine-labeled 
dextran (Mw 70,000 Sigma-Aldrich, USA) according to the above mentioned procedure. 
2.3 Preparation and Characterization of SD/DNA Nanocomplexes  
The SD/DNA nanocomplexes were freshly prepared by complex coacervation method. 
Complexes were prepared by adding equal volumes of diluted SD solution and pDNA solution at 
different N/P ratios (nitrogen to phosphate ratio) followed by vortexing for 20 sec and incubation 
at room temperature for 15 min. The DNA complexation capability of SD was confirmed by 
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agarose gel electrophoresis. SD/DNA complexes at different N/P ratios (1:1, 2:1, 3:1, 4:1, 5:1 
and 10:1) containing 0.5 μg DNA in each N/P ratio were loaded in 1% agarose gel having 
ethidium bromide as DNA visualizer. The gel was run in 1X TAE running buffer at 100 V for 30 
min and subsequently the gel image was captured by gel documentation system (Gel Doc™ EZ 
System, USA). The particle size (hydrodynamic diameter) of SD/DNA complexes was measured 
by dynamic light scattering (DLS) using a Malvern Zetasizer (Zetasizer 3000, Malvern, USA). 
Prior to measurement, SD/DNA complexes were freshly prepared at different N/P ratios of 1:1, 
2:1, 3:1, 4:1, 5:1, 10:1 and 20:1 as described above. The zeta potential of all complexes was also 
measured using the same instrument. 
2.4 Fabrication of Polydimethyl Siloxane (PDMS) Stamps Containing Micropillar 
Arrays  
PDMS stamps were fabricated using silicon master containing microwell arrays of diameters 300 
µm as described previously [26]. Briefly, a mixture of pre-polymer silicone elastomer base 
solution and curing agent (Sylgard 184, Dow Corning Corporation, Midland, MI) at volume ratio 
of 10:1 was degassed for 10 min in a vacuum chamber to remove any bubbles and then poured 
onto the silicon master patterned with a SU-8 photoresist. It was further cured at 75°C for 45 
min. PDMS stamps containing the micropillars were peeled from the masters. 
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2.5 Fabrication of Hydrogel Microwell Arrays 
The generated PDMS stamps were subsequently used for fabrication of non-adhesive 
polyethylene glycol dimethacrylate (PEGDMA) microwell arrays on a glass slide. For covalent 
attachment of PEG hydrogel microwells to the glass slide, sodium hydroxide-treated glass slides 
were coated with 3-trimethoxysilyl polymethacrylate (TMSPMA) [23]. A micropillar PDMS 
stamp was placed on an evenly distributed PEGDMA 1000 (Sigma-Aldrich, USA) solution 
containing 1% (w/w) photoinitiator Irgacure-1959 (Ciba AG CH-4002, Basel, Switzerland) on 
the glass slide and then photocrosslinked by exposure to UV light (350–500 nm wavelength, 
5W/cm2) for 45 s using the OmniCure Series 2000 curing station (EXFO, Canada). After 
photocrosslinking of PEGDMA, the PDMS stamp was peeled from the substrate. This led to 
fabrication of 2×2 cm2 device of hydrogel microwell arrays. 
2.6 Generation and Characterization of 3D Multicellular Spheroids 
Microwell arrays (2×2 cm2) with a well size of 300 µm were sterilized in 6-well plates using 
70% isopropanol under UV light for 30 min and washed with DPBS three times. HeLa cell 
suspension (100 µL, 1×107 cells/mL) was seeded onto each array and cells were allowed to settle 
in the microwells by gravity for 30 min. This step was repeated one more time to ensure 
complete filling of the microwells. The microwell array was then washed gently three times with 
DPBS to remove undocked cells. The cell-seeded devices were cultured in DMEM with 10% 
FBS in humidified incubator at 37°C. The culture media was changed every day. 
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To evaluate the spatial cell distribution in the 3D spheroids, spheroids were stained by Ki-67 
(proliferation marker)/PI (cell death marker). 3D HeLa spheroids grown in 300 µm size 
microwells were harvested on day 2. Spheroids were incubated with PI (1:1000) diluted in 
growth media inside the CO2 incubator for 2 h. Subsequently, they were washed and fixed with 
4% paraformaldehyde for 20 min followed by washing with DPBS three times. Spheroids were 
further fixed with 95% methanol on ice for 15 min and permeabilized by 0.1% TritonX-100 (in 
3% BSA) for 1 h. Then, they were stained with primary antibody Ki-67 (H-300) (Santa Cruz, 
USA, 1:100) diluted in 3% BSA by incubation at 4°C overnight. After washing with DPBS three 
times, the spheroids were stained with Alexa-Fluor conjugated anti-rabbit secondary antibody 
(Santa Cruz, USA, 1:500) for 1 h at room temperature. 
2.7 Evaluation of The Transfection of SD/DNA on 2D Monolayer Cells and 3D 
Spheroids  
For in vitro transfection in 2D monolayer cells and 3D spheroids, both luciferase and GFP 
plasmid DNA (pDNA) were used. Before transfection, 1×105 HeLa cells or 20 spheroids were 
seeded on 24 well plates and cultured for 24 h in complete media. Freshly prepared SD/DNA 
nanocomplexes at different N/P ratios (1:1, 2:1, 3:1, 4:1, 5:1 and 10:1) containing 1 μg DNA in 
each ratio were added to the cells in serum-free media. After incubation for 4 h, the transfection 
media was replaced with fresh 10% FBS containing media and further incubated for 20 h in 5% 
CO2 incubator at 37°C. Naked pDNA and PEI/DNA complex (N/P ratio 10:1) were used as 
negative and positive control, respectively. After 24 h transfection, the luciferase activity was 
assayed by luminescence spectrophotometer and the EGFP (enhanced green fluorescence 
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protein) expression of transfected cells was observed by confocal laser scanning microscopy 
(FV1000, Olympus) or western blot.  
For confocal observation, the transfected 2D cells were fixed by 4% paraformaldehyde 
followed by nuclear staining with Hoechst at room temperature for 30 min while the transfected 
3D spheroids were fixed followed by nuclear staining with Hoechst at 4 °C overnight. The GFP 
expression was further determined by western blot assay according to the standard protocol. The 
transfected cells were first lysed by RIPA buffer on ice for 1 h and the western blot assay was 
carried out after treating the cell lysate with different antibodies including anti-EGFP-TAG 
mouse primary antibody (Thermo Scientific, USA), anti-beta-actin mouse primary antibody 
(Thermo Scientific, USA) and the Dylight 680 fluorescently labeled Goat Anti-mouse as 
secondary antibody (Thermo Scientific, USA). For luciferase expression, pGL2-Luc transfected 
cells were lysed. Then, the luciferase expression for each group was assayed by Pierce Firefly 
Luc One-step Glow Assay Kit (Thermo Scientific, USA). Induction was normalized to protein 
concentration determined by a Commassie (Bradford) Kit (Thermo Scientific, USA). 
2.8 In Vitro Cytotoxicity Assay 
For viability assay, 1×105 cells HeLa cells or 20 spheroids were seeded into 24-well plate and 
cultured for 24 h in complete media. Freshly prepared SD/DNA nanocomplexes at different N/P 
ratios (1:1, 2:1, 3:1, 4:1, 5:1 and 10:1) containing 1 μg DNA in each ratio were added to the cells 
with serum-free media. After incubation for 4 h, the transfection medium was replaced with fresh 
10% FBS containing medium and further incubated for 20 h in 5% CO2 incubator at 37°C. 
Naked pDNA and PEI/DNA complex (N/P ratio 10:1) were used as negative and positive 
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control, respectively. After 24 h transfection, the old culture media was replaced by 10% 
alamarBlue® Cell Viability Assay solution (Thermo Scientific, USA) in complete DMEM media 
(containing 10% FBS). After 4 h incubation, the OD value at 595 nm of each well was measured 
by microplate spectrophotometer (Biotek, USA). All experiments were repeated at least three 
times with at least 3 replicates to ascertain reproducibility.  
2.9 Comparison of Cellular Uptake of SD/DNA Complex on 2D Monolayer Cells and 3D 
Spheroids 
The cellular uptake of Rhodamine-conjugated SD (RSD) polymer and RSD/DNA complex at 
N/P ratios of 3:1 and 5:1 was carried out in 2D monolayer cells and 3D spheroids. Before 
cellular uptake study, the RSD/DNA complexes were freshly prepared as discussed above and 
the complexes containing 1 μg DNA in each weight ratio were added to the cells in serum free 
media followed by incubation in CO2 incubator at 37 °C for 4 h. The 2D cells and 3D spheroids 
were fixed by 4% paraformaldehyde for 20 min followed by nuclear staining with Hoechst. The 
cells were then imaged by confocal microscopy. The images were obtained as a Z-stack with a 
step size of 5 microns using 40X objective. 
2.10 Statistics 
Cell viability, luciferase activity and quantified western blot data was expressed as means ± SEM 
and the data of characterization of nanocomplexes and spheroids was expressed as means ± SD. 
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Student’s paired t-test was used for comparisons between two groups. Multiple comparisons 
were done using one-way/two-way ANOVA followed by Tukey's post hoc test (OriginPro8 SRO 
v. 8.07). p-values less than 0.05 was considered significant. 
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3.0  RESULTS AND DISCUSSION 
3.1 Characterization of SD 
For successful gene therapy, the gene carrier should show efficient transfection and be safe. To 
achieve this, we first synthesized dextran-based gene delivery vector through conjugating 
cationic spermine as shown in Figure 2A. There are different methods to conjugate the cationic 
spermine to polysaccharide dextran backbone [1]. The conjugation using CDI is one of the most 
convenient method [17]. To avoid any crosslinking, excess amount spermine was used to react 
with dextran through CDI. The synthesis of SD was characterized by 1H-NMR (Figure 2B), 
FTIR (Figure 2C) and elemental analysis (Figure 2D). 
The 1H-NMR spectra showed the characteristic peaks of spermine at 1.5, 1.6-1.7 and 2.5-
2.7 ppm [41]. Dextran showed the characteristic peaks at 3.5-3.7, 3.7-3.85, 3.9-4.1 and 5 ppm 
[36]. After conjugation of spermine with dextran, the appearance of proton peaks of spermine at 
1.5-2.0 ppm along with the characteristic peaks of dextran indicated successful synthesis of SD.  
The FTIR spectra (Figure 2C) showed the typical absorbance peaks of spermine at 3255 cm-1 (N-
H stretching of primary amine) and 1647 cm-1 (N-H bending of primary amine). Dextran showed 
a broad peak at 3440 cm-1 corresponding to the hydrogen bonded O-H stretching of hydroxyl 
groups. After reaction of spermine with dextran through CDI, the appearance of absorbance peak 
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at 1738 cm-1 corresponding to C=O stretching of carbamate group (-NH-CO-O), further 
providing the evidence of the synthesis of SD. 
 
Figure 2. Synthetic route of SD and Characterization of SD 
A. Synthetic schema of SD; B. 1H-NMR spectra of spermine, dextran and SD; C. FTIR spectra of spermine, 
dextran and SD; The peak at 1738 cm-1 corresponds to C=O stretching of carbamate group (-NH-CO-O); D. 
Elemental Analysis of SD. 
The synthesized product was also characterized by elemental analysis (Department of 
Chemistry, Zhejiang University, China) as shown in Figure 2D. From 1H-NMR results, the 
theoretical nitrogen percentage of SD was 7.5% while the actual nitrogen percentage in SD 
determined from elemental analysis was 8.32%. This is helpful to calculate the N/P ratio of 
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SD/DNA during complex formation [7]. The N/P ratio is more reliable parameter compared to 
weight ratio because the N/P ratio is directly related to the positive charge of polymer and the 
negative charge of DNA as the nanocomplexes are formed through ionic interactions between 
phosphate and amine of DNA and polymer, respectively. 
3.2 Characterization of SD/DNA Nanocomplexes 
SD/DNA nanocomplexes were formed by self-assembled complex coacervation method through 
electrostatic interactions of negatively charged pDNA with positively charged SD polymer [20]. 
The complex formation was confirmed by agarose gel electrophoresis as shown in Figure 3A. 
The plasmid DNA was only partly condensed by SD at lower N/P ratio (1:1) through ionic 
interactions, which suggested that the complexation capability of SD is not enough to compact 
all DNA at this ratio. With the increase of N/P ratio, the migration of DNA was completely 
retarded when the N/P ratio was more than 3:1, which indicates the complete complexation of all 
DNA by SD.  
Since the hydrodynamic size and surface charge of nanocarriers are very important for drug 
and gene delivery, the average particle size and z-potential of the SD/DNA complexes were 
determined by dynamic light scattering (DLS). In Figure 3B, it can be seen that the average 
particle size of SD/DNA complexes decreased gradually with increase in N/P ratio. At low N/P 
ratio (1:1), the particle size was higher (97.1 ± 13.6 nm) due to incomplete complexation of 
DNA with SD. The particle size and morphology of SD/DNA complex at N/P ratio 3:1 were 
further characterized by TEM as shown in Figure 3B. TEM image also showed that the particle 
sizes of SD/DNA complexes were around 45-65 nm with some aggregates, which were well 
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correlated to the DLS data. The particle size determined by DLS was slightly higher than that of 
the TEM image because DLS measurement carried out in aqueous media. The morphology of the 
complex was spherical in shape. 
 
Figure 3. Characterization of SD/DNA nanocomplexes 
A. Agarose gel electrophoresis of SD/DNA nanocomplexes; B. Size of SD/DNA nanocomplexes at 
different N/P ratios and size distribution and TEM of SD/DNA nanocomplexes at N/P ratio 3:1; C. zeta-
potential of SD/DNA nanocomplexes at different N/P ratios. The results were expressed as means ± SD. 
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Zeta potential is an important parameter for cellular uptake. Positive zeta potential is 
reported to favor cellular uptake because cell membrane possesses negative charge, which 
facilitate better cellular uptake of positively charged particle through electrostatic interaction. 
The zeta potential of SD/DNA nanocomplexes at different N/P ratio was shown in the Figure 3C. 
At N/P ratio 1:1 was negative because the excessive negative DNA could not be fully condensed 
by positive SD. When N/P ratio reached to 2:1, the zeta potential of nanocomplexes became 
positive and remained almost constant with increase in N/P ratio of SD/DNA complex due to 
complexation of pDNA by SD as observed in agarose gel electrophoresis assay. This positive 
charge can help the SD/DNA nanocomplexes interact with the negatively charged cellular 
membrane and enhance the cellular internalization and transfection efficiency of the 
nanocomplexes [24]. Additionally, the proton sponge effect of spermine has been shown to 
increase transfection efficiency [9]. The high degree of protonation makes it easier for the DNA 
to escape from the endosome and be trafficked through the cytoplasm to the nucleus for gene 
expression. Also, the positive charge of the SD/DNA nanocomplexes would improve the cell-
carrier interaction and cellular uptake of nanocomplexes. 
3.3 Transfection and Cytotoxicity of SD/DNA Nanocomplexes on 2D Monolayer Cells 
Safety is one of the most important concerns for the application of the non-viral gene delivery 
vehicles. The toxicity of SD/DNA nancomplexes at different weight ratios was investigated by 
an alamarBlue® Cell Viability Assay. Branched PEI (25 kDa)/pDNA complex at N/P ratio 10:1 
was used as positive control because branched PEI (25 kDa) is most widely used non-viral 
carrier with high transfection efficiency at N/P ratio 10:1. [16, 32]. From the cell viability assay 
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as shown in Figure 4A, it was found that the commercial reagent PEI (25 kDa) showed high 
cytotoxicity, which agreed with most of the non-viral gene delivery studies [18, 37]. SD/DNA 
complexes showed dose-dependent cytotoxicity on 2D monolayer cells. The cell viability was 
>80% for 2D cells at low N/P ratio (N/P ratio from 1:1 to 4:1), which was much lower than that 
of positive control PEI/pDNA complexes. However, SD/DNA complexes showed comparable 
toxicity to PEI at higher N/P ratio (10:1). The high cytotoxicity of SD/DNA at N/P ratio 10:1 
may be due to their high positive charge [44], which can cause cell membrane damage. Also, it 
was reported that the cationic polymers with the primary amine could interfere with critical 
intracellular processes of cells [11].  
The transfection efficiency of SD/DNA nanocomplexes were investigated by luciferase 
activity assay, confocal fluorescence observation and western blot technique. The levels of 
luciferase activity (RLU/mg protein) were obtained following transfection with a range of 
SD/DNA at N/P ratio from 1:1 to 10:1 (Figure 4B). The luciferase activity increased with 
increase in N/P ratio of SD/DNA complex up to 3:1 then the luciferase activity slightly 
decreased with further augmentation of N/P ratio. The luciferase activity obtained by SD/DNA 
complex at N/P ratio 3:1 was almost comparable to that of PEI at N/P ratio 10:1. There was no 
significant difference between PEI group and SD N/P ratio 3:1 and 5:1 group (p>0.05). At lower 
N/P ratio (1:1 and 2:1), the transfection efficiency was lower than PEI/DNA nanocomplexes. 
This may be because the SD polymer cannot fully condense the plasmid DNA to form 
nanocomplexes with positive charge and small size (Figure 3A, B and C). From N/P ratio 3:1 to 
N/P ratio 5:1, the well-formed SD/DNA nanocomplexes have good DNA complexation 
properties and showed good transfection behavior. However, at higher N/P ratio (N/P=10:1), the 
transfection efficiency decreased significantly compared to PEI as well as SD/DNA 
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nanocomplexes at 3:1-5:1 ratios. This might be due to the significant cytotoxicity of the 
excessive positive charges on SD (Figure 4A). 
The luciferase assay method is very sensitive but sometimes the quenching of 
firefly luciferase-luciferin bioluminescence would influence the transfection results. Also, the 
above data has reported the total reporter gene in HeLa cells, but do not indicate the proportion 
of cells transfected or the localization of gene delivery vector in the cells. To address these 
issues, the reporter gene was switched to pcDNA3-EGFP to investigate the localization of 
reporter EGFP expression in 2D monolayer cells using confocal microscopy. Figure 4C showed 
EGFP expression in 2D HeLa cells after transfection with pcDNA3-EGFP delivered by SD and 
PEI as delivery vectors. The green fluorescence protein signal was weaker in HeLa cells 
transfected by naked DNA and SD/DNA complexes with low N/P ratio (1:1). However, stronger 
fluorescent intensity was observed when 2D cell were transfected by SD/DNA with N/P ratio 3:1 
and 5:1. This result indicates that the SD/DNA nanocomplexes internalized into cytoplasm 
followed by GFP expression. 
For successful gene therapy, the efficacy of therapeutic gene expression not only depends on 
the gene transfection signal but also on the amount of protein expression. To further confirm 
EGFP protein expression after transfection in 2D cells, we performed western blot assay as 
shown in Figure 4D. The relative amount of each immunoprecipitated protein was quantified 
with ImageJ software. The results showed that the EGFP expression of SD/DNA complex 
increased with increase in N/P ratio. SD/DNA complex at N/P ratio of 3:1 and 5:1 groups 
showed the highest EGFP expression which was almost equivalent to PEI group and the result 
correlated well with the luciferase assay and confocal observation. 
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Therefore, SD/DNA complex at N/P ratio of 3:1 and 5:1 showed good transfection efficiency 
(almost equal to that of PEI/DNA) with minimal toxicity (much less than PEI/DNA). It is already 
reported that dextran is biocompatible, biodegradable and nontoxic polysaccharide with low 
transfection efficiency due to non-ionic nature [10, 19]. Conjugation of cationic spermine with 
dextran also resulted in low toxicity and efficient gene delivery in 2D cells.  
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Figure 4. Cytotoxicity and transfection efficiency of SD/DNA nanocomplexes in 2D monolayer HeLa cells 
A. Cell viability of 2D monolayer cells after transfection with SD/DNA and PEI/DNA nanocomplexes at 
different N/P ratioa; B. Luciferase activity after 24 h SD/pGL2 nanocomplexes transfection at different N/P 
ratios. NS, no significant difference; * significant difference (One-way ANOVA, p<0.05); C. Confocal 
images of 2D monolayer HeLa after 24 h SD/pEGFP nanocomplexes transfection at different N/P ratios. 
Top panels: Hoechst nuclear stain (blue); middle panels: EGFP expression (green); bottom panels: Merged 
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images; D. Western blot of EGFP from 2D monolayer HeLa after 24 h transfection with SD/pEGFP 
nanocomplexes at different N/P ratios and optical density quantification of EGFP/b-actin by the ImageJ 
software. The results were expressed as means ± SEM. 
3.4 Characterization of 3D Spheroids 
Several studies utilized different techniques and methods to form 3D spheroids for drug 
screening and other biological studies. Some of them cannot maintain intact 3D structure due to 
less stability and resulted in failure of drug screening study [39]. Some other conventional 
techniques such as Non-adherent surfaces, Spinner flask and NASA rotary cell vessel culture 
techniques cannot fabricate 3D spheroids with uniform and controlled sizes [13, 22]. Size 
uniformity is very important because spheroids with different sizes may have different physical 
and biological properties such as presence of hypoxia, metabolic stress due to nutrient/metabolite 
diffusion limitations. Non-uniform size of spheroids may also influence the experimental 
reproducibility by affecting penetration of drug or gene delivery vectors. To overcome these 
problems, we developed a simple multilayer replica molding technique to prepare intact 3D 
spheroids with uniform and controlled sizes. In our study, polydimethyl siloxane (PDMS) and 
polyethylene glycol dimethacrylate (PEGDMA) were serially replica molded to develop 
hydrogel device (Figure 5A). PDMS micro-array is widely used for microfluidic and nano-
imprint lithography and few studies have utilized it for fabricating hydrogel microwell devices 
for cancer spheroids and stem cell embryoid bodies [28]. 
Our technique could produce hundreds of spheroids with uniform size (250 ± 28 μm) 
from one PEGDMA gel device in a high throughput manner (each 2×2 cm2 device contained 
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approximately 625 spheroids of 300 μm sizes) (Figure 5B, C). The 2-day old spheroids were 
harvested by pipetting and most of them remained intact and tight (Figure 5C, E). After 
dissociation into single cell suspension by trypsin treatment, the average number of cells in each 
harvested spheroid was around to be 1143 ± 110. 
 
Figure 5. Fabrication and characterization of 3D spheroids  
A. Schematic of fabrication of 3D spheroids using PDMS and PEGDMA hydrogel; B. Uniform spheroids 
cultured in hydrogel device; C, E. 2-day old harvested spheroids; D. Single spheroid in a hydrogel 
microwell; F. Hoechst nuclear stain; G.PI Dead cell stain; H. Ki67 marker stain; I. Merged images. 
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To assess the spatial cellular distribution of proliferating and apoptotic cells in the spheroids, 
Ki67 immunostaining was performed. Ki67 protein is present during all active cell phase 
including G1, S, G2, and mitosis except resting cell G0 phase [35]. This property makes it an 
excellent marker for proliferating cellular population [14]. It is reported that spheroids with 
diameter of 400 μm and larger size would have zones of proliferating cells on the outside and 
quiescent cells on the inside due to nutrient and oxygen transport limitations [40]. However, in 
this study, we used spheroids with smaller sizes (250 ± 28 μm) that were harvested on day 2. As 
shown in Figure 5F, 3D spheroids exhibited Ki67-positive cells with few PI-positive (dead) cells 
in the central core of the spheroids (Figure 5G). Based on these observations, HeLa cells can 
form uniform 3D spheroids in our PEGDMA-device system and these spheroids can be further 
employed as the avascular microtumor model for studying drug and gene delivery efficiency. 
3.5 Evaluation of The Transfection and Cytotoxicity of SD/DNA Complexes in 3D 
Spheroids 
The gene transfection efficiency and cytotoxicity of SD/DNA complex at different N/P ratios 
was evaluated in 3D spheroids as shown in Figure 6. To compare the difference of the 
cytotoxicity of the polymeric nanocomplexes in 3D spheroids, an alamarBlue® cell viability 
assay was performed. Figure 6A showed the cell viability after 24 h transfection in 3D spheroids. 
There was no significant difference in cell viability in 3D spheroids transfected by SD/DNA 
complexes at all N/P ratios and PEI. In 3D spheroids, SD/DNA complexes at N/P ratios of 3:1 
and 5:1 showed higher cell viability, which was similar to that observed in 2D cells. The higher 
N/P ratio of SD/DNA complex (10:1) and PEI/DNA complex showed higher cytotoxicity as well 
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as transfection efficiency in 2D cells especially for PEI. However, this trend was not observed in 
3D spheroids. 
Figure 6B showed that the overall luciferase activity was very low (10 fold lower than 
that on 2D cells). And there was no significant difference in the luciferase expression among 
different N/P ratios of SD/DNA nanocomplexes and PEI. Since N/P ratio dependent transfection 
was obtained in 2D monolayer cells, it was expected that the same trend would be obtained in the 
3D spheroids. However, we didn’t see such results in 3D model. The SD/DNA complex at N/P 
ratio 3:1 to 10:1 showed the similar efficiency as the naked DNA suggesting that the SD/DNA 
nanocomplexes induced low transfection in 3D spheroids without any dose-dependent behavior.  
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Figure 6. Cytotoxicity and transfection efficiency of SD/DNA nanocomplexes in 3D spheroids 
A. Cell viability of 3D spheroids after 24 h SD/pGL2 nanocomplexes transfection at different N/P 
ratios; B. Luciferase activity after 24 h SD/pGL2 nanocomplexes transfection at different N/P 
ratios. C. Confocal images of 3D spheroids after 24 h SD/pEGFP nanocomplexes transfection at 
different N/P ratios. Top panels: Hoechst nuclear stain (blue); bottom panels: EGFP expression 
(green); D. Western blot of EGFP expression after 24 h transfection with SD/pEGFP 
nanocomplexes at different N/P ratios and optical density quantification of EGFP/b-actin by the 
ImageJ software. The results were expressed as means ± SEM. 
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We also observed the transfection efficiency of these polymeric vectors in 3D spheroids by 
confocal microscopy. In Figure 6C, it can be observed that the EGFP expression of the 
transfected cells by SD/DNA and PEI/DNA complexes at all N/P ratios were much lower than 
that on 2D cells. It was reported that EGFP expression was confined to the outermost 3–5 cell 
layers in some other spheroids, but most of the proportion of cells expressing EGFP is less than 
5% of the total population [31]. We obtained similar transfection in PEI/DNA group and 
SD/DNA ay N/P ratios of 3:1 and 5:1 groups, where it was observed that EGFP expression was 
limited to the peripheral cells of the spheroids. The western Blot (Figure 6D) also showed similar 
results as confocal results that PEI and SD/DNA at N/P ratio 3:1 and 5:1 exhibited less protein 
expression.  
It is commonly known that the spheroids display extensive cell-cell contact, a 
concomitant elevation in the interstitial pressure and demonstrate a significant resistance to 
chemotherapy and radiotherapy [8]. This may also be true for the non-viral gene delivery 
systems. The extracellular matrix (ECM) and multicellular barriers with high cell density 
inhibited the nanocomplexes penetrating into the deep areas of 3D spheroids. Some other studies 
on gene delivery in 3D spheroids also showed similar low transfection efficiency in spheroids [4, 
25, 30, 31]. Further experiments are required to confirm the diffusion and penetration barriers for 
non-viral vectors . It is a well-known dilemma that the transfection efficiency and cytotoxicity of 
non-viral gene delivery is closely related, which suggests that the higher transfection efficiency 
may be associated with higher cytotoxicity. In our study, we observed this phenomenon and 
demonstrated it was true for the transfection on both of 2D and 3D spheroids. Taken all of above 
transfection results together (luciferase assay, confocal fluorescence images and western blot 
 28 
assay), SD demonstrated good transfection efficiency when tested in conventional 2D monolayer 
cells, while both of SD and PEI did not show high transfection efficiency in 3D spheroids. Only 
parts of the peripheral cells (outermost cell layers) in 3D spheroids were transfected by PEI/DNA 
and SD/DNA complexes (N/P ratio 3:1 and 5:1). These results are similar to the few published 
studies on in vitro 3D spheroid model for gene delivery [5] [31] and also suggested the possible 
relevant clinical observation that non-viral gene delivery has low efficiency in the solid tumors 
or 3D architectural tissues in vivo. These data suggests that the biological barriers present in 3D 
tissue structure serve as a major obstacle to block the penetration of non-viral gene delivery 
vector into the 3D tissues, thus further hampering gene delivery and transfection efficiency. To 
further test the penetration of SD and PEI vectors, we compared the cellular uptake of these 
vectors in both 2D monolayer cell and 3D spheroids. 
3.6 Evaluation of The Cellular Uptake of Rhodamine-conjugated Spermine-Dextran 
(RSD) in 2D Cells and 3D Spheroids  
Above transfection results showed that the transfection efficiency of SD/DNA (N/P ratio 3:1 and 
5:1) and PEI/DNA were less in 3D spheroids than that in 2D cells and most of the transfected 
cells in 3D spheroids were located at the outer layers. This result suggested that one of the 
reasons for this phenomenon may be due to their failure to penetrate in the 3D tissues [27, 38]. 
To further assess the penetration behavior of SD/DNA nanocomplexes in 3D cells, we used 
fluorescently-labeled SD, Rhodamine-conjugated Spermine-Dextran (RSD), to track the cellular 
uptake of the non-viral vector by using confocal microscopy. The RSD/DNA complexes at N/P 
ratios of 3:1 and 5:1 were used in cellular uptake study due to their best transfection efficiency in 
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2D cells and 3D spheroids. From Figure 7, it was observed that the cellular uptake of RSD/DNA 
nanocomplexes at N/P ratio of 3:1 and 5:1 (Figure 7B, C) was higher than free RSD in 2D 
monolayer (Figure 7A). However, the cellular uptake of the same was significantly lower in 3D 
spheroids compared to that in 2D monolayer cells and resulted in low transfection efficiency in 
3D spheroids. The uptake of the RSD/DNA nanocomplexes by the cells in 3D spheroids could be 
depicted by the weak fluorescence signal in the peripheral layer of the 3D spheroids (Figure 7E, 
F). This suggested that the RSD/DNA nanocomplexes were only able to accumulate in cells at 
the exterior of the 3D spheroid and most of the non-viral vectors were blocked in the peripheral 
layers. This result also agreed with the transfection result in 3D spheroids (Figure 6C). The 
different internalization behavior between on 2D monolayer cells and 3D spheroids cells might 
be due to the biological barrier in 3D spheroids. This would largely influence the transfection 
and cytotoxicity behavior in the 2D cells and 3D spheroids. Future experiments concerning the 
different microenvironment and cellular trafficking in 3D spheroids should be done to further 
disclose the mechanism that induce the different transfection behavior of gene delivery system in 
2D monolayer cells and 3D spheroids. 
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Figure 7. The cellular uptake of RSD/DNA nanocomplexes after 4 h incubation. 
Cellular uptake of RSD polymer (A),  RSD/DNA nanocomplexes at N/P ratio of 3:1 (B) and 5:1 
(C) in 2D cell monolayers;  
Cellular uptake of RSD polymer (D), RSD/DNA nanocomplexes at N/P ratio of 3:1 (E) and 5:1 
(F) in 3D spheroids; Blue: Hoechst nuclear stain; Red: RSD/DNA nanocomplexes. Inset shows 
high magnification (80X) images. The images represent the central slice of the z-axis scan. 
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4.0  CONCLUSION AND FUTURE DIRECTION 
The transfection efficiency of synthesized SD was compared in 2D monolayer cells and 3D 
spheroids. It was found that the transfection efficiency, cytotoxicity and cellular uptake of SD in 
3D spheroids were much lower than in 2D cells. The possible reason might be the biological 
barriers and strong cell-cell interactions in 3D spheroids hindering the non-viral vectors 
penetration into the inner core of the spheroids. Although 3D spheroid model cannot fully 
resemble the in vivo 3D tissues and solid tumors a, they provide useful information of drug or 
gene delivery vector penetration in tissues and can better predict the in vivo behavior than 2D 
monolayer cell models. A follow-up study will investigate the detailed mechanisms behind the 
poor transfection in 3D and possible avenues to overcome these barriers. This work will refine 
the 3D drug and gene delivery system testing model and provide a promising platform for the 
drug and vector screening prior to the in vivo study. 
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APPENDIX A 
ABBREVIATION 
Term    Abbreviation 
AGE    Agarose Gel Electrophoresis  
ECM    Extracellular Matrix 
EGFP    enhanced Green Fluorescence Protein 
FTIR    Fourier Transform Infrared Spectroscopy 
MCTS    Multicellular Tumor Spheroids 
PBS    Phosphate Buffered Saline 
PDMS    Poly-Dimethylsiloxane  
PEGDMA   Poly-(Ethylene Glycol) Diamethacrylate  
PEI    Poly-ethyleneimine 
PFA    Poly-formaldehyde 
PI    Prodium Iodide 
RLU    Relative Light Unit  
RSD    Rhodamine-labeled Spermine-Dextran 
SD    Spermine-Dextran 
TEM    Transmission Electron Microscopy 
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